Jump to main content
Jump to site search

Issue 12, 2012
Previous Article Next Article

Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical

Author affiliations

Abstract

Polyphenolic compounds derived mainly from plant products have demonstrated neuroprotective properties in a number of experimental settings. Such protective effects have often been ascribed to antioxidant capacity, but specific augmentation of other cellular defences and direct interactions with neurotoxic proteins have also been demonstrated. With an emphasis on neurodegenerative conditions, such as Alzheimer's disease, we highlight recent findings on the neuroprotection ascribed to bioactive polyphenols capable of directly interfering with the Alzheimer's disease hallmark toxic β-amyloid protein (Aβ), thereby inhibiting fibril and aggregate formation. This includes compounds such as the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) and the phytoalexin resveratrol. Targeted studies on the biomolecular interactions between dietary polyphenolics and Aβ have not only improved our understanding of the pathogenic role of β-amyloid, but also offer fundamentally novel treatment options for Alzheimer's disease and potentially other amyloidoses.

Graphical abstract: Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical

Back to tab navigation

Article information


Submitted
28 Mar 2012
Accepted
11 Jul 2012
First published
24 Aug 2012

Food Funct., 2012,3, 1242-1250
Article type
Review Article

Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical

S. D. Smid, J. L. Maag and I. F. Musgrave, Food Funct., 2012, 3, 1242
DOI: 10.1039/C2FO30075C

Social activity

Search articles by author

Spotlight

Advertisements